BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1290725)

  • 1. Effect of pyridoxine on tumor necrosis factor activities in vitro.
    Hofsli E; Waage A
    Biotherapy; 1992; 5(4):285-90. PubMed ID: 1290725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo.
    Beyaert R; Vanhaesebroeck B; Suffys P; Van Roy F; Fiers W
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9494-8. PubMed ID: 2556714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WEHI-164 clone 2F: in vitro antitumor effects of tumor necrosis factor and gamma-interferon.
    Lattime EC; Stutman O
    Nat Immun; 1992; 11(1):34-45. PubMed ID: 1611280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WEHI-13VAR: a stable and sensitive variant of WEHI 164 clone 13 fibrosarcoma for tumor necrosis factor bioassay.
    Khabar KS; Siddiqui S; Armstrong JA
    Immunol Lett; 1995 May; 46(1-2):107-10. PubMed ID: 7590904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
    Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antisera against recombinant tumor necrosis factor and the monocyte-derived cytotoxin(s) on monocyte-mediated killing of various tumor cells.
    Nissen-Meyer J; Espevik T
    Cell Immunol; 1987 Oct; 109(2):384-96. PubMed ID: 3478143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of hydroperoxy fatty acid inhibition of cell growth and the lack of effect on tumour necrosis factor-induced cytotoxicity in WEHI clone 13 cells.
    Nøding R; Brekke OL; Bjerve KS
    Biochim Biophys Acta; 1997 Jul; 1347(1):82-92. PubMed ID: 9233690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
    Belizario JE; Dinarello CA
    Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of n-3 and n-6 fatty acids on tumor necrosis factor cytotoxicity in WEHI fibrosarcoma cells.
    Brekke OL; Espevik T; Bardal T; Bjerve KS
    Lipids; 1992 Mar; 27(3):161-8. PubMed ID: 1522759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS).
    Leung KN; Mak NK; Fung MC; Hapel AJ
    Immunology; 1994 Jan; 81(1):65-72. PubMed ID: 8132222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J; Ribolini A
    J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor induces activation of mitochondrial succinate dehydrogenase.
    Levrat C; Larrick JW; Wright SC
    Life Sci; 1991; 49(23):1731-7. PubMed ID: 1943475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release.
    Brekke OL; Espevik T; Bjerve KS
    Lipids; 1994 Feb; 29(2):91-102. PubMed ID: 8152351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine.
    Beyaert R; Vanhaesebroeck B; Heyninck K; Boone E; De Valck D; Schulze-Osthoff K; Haegeman G; Van Roy F; Fiers W
    Cancer Res; 1993 Jun; 53(11):2623-30. PubMed ID: 8495426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of iron in the cytotoxicity of tumor necrosis factor.
    Warren S; Torti SV; Torti FM
    Lymphokine Cytokine Res; 1993 Apr; 12(2):75-80. PubMed ID: 8324080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum protease inhibitor abrogation of Newcastle disease virus enhancement of cytolysis by recombinant tumor necrosis factors alpha and beta.
    Rood PA; Lorence RM; Kelley KW
    J Natl Cancer Inst; 1990 Feb; 82(3):213-7. PubMed ID: 2296051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytostatic and cytotoxic effects of tumor necrosis factor alpha on MCF-7 human breast tumor cells are differently inhibited by glucocorticoid hormones.
    Pagliacci MC; Fumi G; Migliorati G; Grignani F; Riccardi C; Nicoletti I
    Lymphokine Cytokine Res; 1993 Dec; 12(6):439-47. PubMed ID: 8123760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor.
    Srinivasan JM; Fajardo LF; Hahn GM
    J Natl Cancer Inst; 1990 Dec; 82(24):1904-10. PubMed ID: 2250311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II.
    Coffman FD; Green LM; Godwin A; Ware CF
    J Cell Biochem; 1989 Feb; 39(2):95-105. PubMed ID: 2541144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancement.
    Brekke OL; Shalaby MR; Sundan A; Espevik T; Bjerve KS
    Cytokine; 1992 Jul; 4(4):269-80. PubMed ID: 1515551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.